247 related articles for article (PubMed ID: 31487270)
1. CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion.
Park J; Zhang X; Lee SK; Song NY; Son SH; Kim KR; Shim JH; Park KK; Chung WY
J Clin Invest; 2019 Dec; 129(12):5381-5399. PubMed ID: 31487270
[TBL] [Abstract][Full Text] [Related]
2. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
3. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
Yaginuma T; Gao J; Nagata K; Muroya R; Fei H; Nagano H; Chishaki S; Matsubara T; Kokabu S; Matsuo K; Kiyoshima T; Yoshioka I; Jimi E
Carcinogenesis; 2020 Aug; 41(8):1038-1048. PubMed ID: 31996896
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
[TBL] [Abstract][Full Text] [Related]
6. MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.
Quan J; Morrison NA; Johnson NW; Gao J
J Cell Biochem; 2014 Oct; 115(10):1787-98. PubMed ID: 24905457
[TBL] [Abstract][Full Text] [Related]
7. Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma.
Quan J; Du Q; Hou Y; Wang Z; Zhang J
Oncol Rep; 2017 Aug; 38(2):850-858. PubMed ID: 28656299
[TBL] [Abstract][Full Text] [Related]
8. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774
[TBL] [Abstract][Full Text] [Related]
9. High-mobility group box 1 induces bone destruction associated with advanced oral squamous cancer via RAGE and TLR4.
Sakamoto Y; Okui T; Yoneda T; Ryumon S; Nakamura T; Kawai H; Kunisada Y; Ibaragi S; Masui M; Ono K; Obata K; Shimo T; Sasaki A
Biochem Biophys Res Commun; 2020 Oct; 531(3):422-430. PubMed ID: 32800556
[TBL] [Abstract][Full Text] [Related]
10. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
Shinriki S; Jono H; Maeshiro M; Nakamura T; Guo J; Li JD; Ueda M; Yoshida R; Shinohara M; Nakayama H; Matsui H; Ando Y
J Pathol; 2018 Mar; 244(3):367-379. PubMed ID: 29235674
[TBL] [Abstract][Full Text] [Related]
11. The downregulation of IGFBP3 by TGF-β signaling in oral cancer contributes to the osteoclast differentiation.
Park J; Jung MJ; Chung WY
Biochem Biophys Res Commun; 2021 Jan; 534():381-386. PubMed ID: 33256984
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL.
Tohyama R; Kayamori K; Sato K; Hamagaki M; Sakamoto K; Yasuda H; Yamaguchi A
J Oral Pathol Med; 2016 May; 45(5):356-64. PubMed ID: 26859422
[TBL] [Abstract][Full Text] [Related]
13. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte elevated gene-1 promotes tumour growth and invasion by inducing EMT in oral squamous cell carcinoma.
Wang Y; Wang T; Sun Y; Sun W; Wang X
Sci Rep; 2017 Nov; 7(1):15447. PubMed ID: 29133850
[TBL] [Abstract][Full Text] [Related]
15. Dual roles of cellular communication network factor 6 (CCN6) in the invasion and metastasis of oral cancer cells to bone via binding to BMP2 and RANKL.
Hochi H; Kubota S; Takigawa M; Nishida T
Carcinogenesis; 2023 Dec; 44(8-9):695-707. PubMed ID: 37590989
[TBL] [Abstract][Full Text] [Related]
16. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
[TBL] [Abstract][Full Text] [Related]
17. Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.
Zhang X; Junior CR; Liu M; Li F; D'Silva NJ; Kirkwood KL
Oral Oncol; 2013 Feb; 49(2):119-28. PubMed ID: 22989723
[TBL] [Abstract][Full Text] [Related]
18. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β-regulated fractalkine as a marker of erosive bone invasion in oral squamous cell carcinoma.
Son SH; Park J; Jung MJ; Lee SK; Kim H; Kim KR; Park KK; Chung WY
Eur J Oral Sci; 2021 Feb; 129(1):e12750. PubMed ID: 33503283
[TBL] [Abstract][Full Text] [Related]
20. Casticin inhibits invasion and proliferation via downregulation of β-catenin and reversion of EMT in oral squamous cell carcinoma.
Xie Y; Zhong L; Duan D; Li T
J Oral Pathol Med; 2019 Nov; 48(10):897-905. PubMed ID: 31318467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
